News About: Pharm. Affairs
1 of 4 medicines approved this year was OTC drug
3 of 4 medicines approved this year were ETC drugs, and the rest was OTC drugs.
According to the Ministry of Food and Drug Safety(MFDS), there were the total 1,427 drug products approved between January and August, a...
Viread leads outpatient prescription market last July, chased by Lipitor
While Gilead Sciences’ Viread was rushing at the top in the outpatient prescription market last July, Lipitor was chasing after it. Among the top 15 medicines, in addition, Chong Kun Dang’s Gliatilin and Daewoong Bio’...
Will opening a pharmacy inside of hospital be possible?
The Administrative Trial Committee’s decision that it would be available to open a pharmacy inside of Gyeongsang National University Hospital located in Gyeongnam has angered the pharmacists’ society.
Allowing to ope...
Daewoong Bio file appeal, “GLIATAMIN and GLIATILIN has no similarity in trademark”
Daewoong Bio said on the 30th “Cognition-enhancing GLIATAMIN and Italfarmaco’s GLIATILIN have no similarity in appearance, name and concept. We’ll immediately file an appeal.”
It was the company’s official position a...
Pouring ‘Tamiflu’ generics raise concerns in pharmacy circles
Pouring generic drugs in the market, caused by recent patent expirations of original drugs, such as Tamifly, are expected to raise concerns in the pharmacy circles.
When it comes to ‘Tamiflu, an influenza treatment w...
‘Large competition’ expected among pharmas over tetravalent flu vaccines
While an influenza vaccine program will start this September, competition for tetravalent flu vaccines is expected to get fiercer than the last year.
The Ministry of Food and Drug Safety(MFDS) revealed information ab...
ETC/OTC ratio stays at 83:17 for 5 years
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won) published the ‘2016 Manufacturing Performance Table for Medicines’ on the 28th. Divided into 2 volumes and a reference section, t...
‘Agents for arteriosclerosis’ manufactured the most, 3 therapeutic categories manufactured for more than KRW 1 trillion
Agents for arteriosclerosis were reportedly manufactured the most last year.
The ‘Medicines Outputs by Therapeutic Category’ totaled by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association on therapeutic...
Quinvaxem Inj manufactured the most last year while Dong-A ST made the most products in top 50
A pharmaceutical product manufactured the most last year was reportedly ‘Quinvaxem Inj.’
The ‘Top 50 Finished Medicine Outputs by Product(2016)’ totaled by the Korea Pharmaceutical and Bio-Pharma Manufacturers Associ...
Discrimination on synthesized drugs over biologics in drug pricing
It was criticized synthesized drugs have been discriminated also in drug pricing due to supports leaning only on the biotech field.
A source from the pharmaceutical industry reported there were different drug pricing...
